Barclays’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-105,500
Closed -$34.8M – 5505
2024
Q2
$34.8M Buy
+105,500
New +$37.3M 0.01% 739

Other funds holding WST

Barclays's WST Position: Q3 2026 in Review

Barclays reduced its West Pharmaceutical (WST) stake by 17% in Q3 2026, selling an estimated $14.8M and leaving 204,168 shares worth $75.7M. The position accounts for 0.02% of the portfolio, ranked #609.

Barclays first reported a position in WST in Q2 2013 and has held it in 54 quarters since. The position peaked at $88.4M in Q2 2026. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Barclays held 204,168 shares of West Pharmaceutical worth $75.7M as of Q3 2026.
  • Barclays sold 42,031 West Pharmaceutical shares in Q3 2026, an estimated $14.8M.
  • West Pharmaceutical made up 0.02% of Barclays's portfolio in Q3 2026, its #609 holding.
  • Barclays first reported a position in West Pharmaceutical in Q2 2013 and has held it in 54 quarters since.
  • Barclays's West Pharmaceutical position peaked at $88.4M in Q2 2026.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.